BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation
Abstract Induction of immunosuppressive T-regulatory cells (Tregs) is a desirable goal in autoimmunity, and perhaps other immune diseases of activation. One promising avenue is with the bacille-calmette-guérin (BCG) vaccine in autoimmune type 1 diabetes (T1D). Its administration is associated with g...
Guardado en:
Autores principales: | Ryan C. Keefe, Hiroyuki Takahashi, Lisa Tran, Kacie Nelson, Nathan Ng, Willem M. Kühtreiber, Denise L. Faustman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/09f73d65921c45aab18448f13edbdcdf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation
por: Gerdien Mijnheer, et al.
Publicado: (2021) -
Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity
por: Aner Ottolenghi, et al.
Publicado: (2021) -
Eicosapentaenoic acid and 5-HEPE enhance macrophage-mediated Treg induction in mice
por: Toshiharu Onodera, et al.
Publicado: (2017) -
Induction of Foxp3 and activation of Tregs by HSP gp96 for treatment of autoimmune diseases
por: Yuxiu Xu, et al.
Publicado: (2021) -
Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized mice
por: Isabelle Serr, et al.
Publicado: (2016)